Therapeutic immunoglobulin selected for high antibody titer to RSV also contains high antibody titers to other respiratory viruses

Frontiers in Immunology

Volumn 6, Issue AUG, 2015, Pages

  Orange, Jordan S ^a   Du, Wei ^b   Falsey, Ann R ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Clinical Statistics Consulting   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Hyperimmune globulin; Immune deficiency; IVIG; Respiratory viruses; RSV

Indexed keywords

IMMUNOGLOBULIN; RESPIRATORY SYNCYTIAL VIRUS VACCINE;

AFFINITY CHROMATOGRAPHY; ANTIBODY TITER; ARTICLE; CANCER CELL LINE; CELL LYSATE; DIPHTHERIA; ENZYME LINKED IMMUNOSORBENT ASSAY; HEP 2 CELL LINE; HEPATITIS B; HRT 18G CELL LINE; HUMAN; HUMAN CORONAVIRUS 229E; HUMAN CORONAVIRUS OC43; HUMAN METAPNEUMOVIRUS; HUMAN PARAINFLUENZA VIRUS 1; HUMAN PARAINFLUENZA VIRUS 2; HUMAN PARAINFLUENZA VIRUS 3; HUMORAL IMMUNITY; INFLUENZA A; LLC MK2 CELL LINE; MDCK CELL LINE; MEASLES; MRC 5 CELL LINE; NONHUMAN; POLIOMYELITIS; PROTEIN A CHROMATOGRAPHY; RESPIRATORY VIRUS; TETANUS; VERO CELL LINE; VIRUS INFECTION;

EID: 84941274669     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00431     Document Type: Article

References (15)

1. Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, Cunningham-Rundles C, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol (2014) 5:162. doi: 10.3389/fimmu.2014.00162.
2. Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedside. J Clin Immunol (2013) 33(6):1078-87. doi:10.1007/s10875-013-9901-6.
3. Orange JS. Congenital immunodeficiencies and sepsis. Pediatr Crit Care Med (2005) 6:S99-107. doi:10.1097/01.PCC.0000164488.19810.DB.
4. Jesenak M, Banovcin P, Jesenakova B, Babusikova E. Pulmonary manifestations of primary immunodeficiency disorders in children. Front Pediatr (2014) 2:77. doi:10.3389/fped.2014.00077.
5. Cunningham-Rundles C. Key aspects for successful immunoglobulin therapy of primary immunodeficiencies. Clin Exp Immunol (2011) 164(Suppl 2):16-9. doi:10.1111/j.1365-2249.2011.04390.x.
6. Quinti I, Soresina A, Guerra A, Rondelli R, Spadaro G, Agostini C, et al. Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study. J Clin Immunol (2011) 31(3):315-22. doi:10.1007/s10875-011-9511-0.
7. Mikolajczyk MG, Concepcion NF, Wang T, Frazier D, Golding B, Frasch CE, et al. Characterization of antibodies to capsular polysaccharide antigens of Haemophilus influenzae type b and Streptococcus pneumoniae in human immune globulin intravenous preparations. Clin Diagn Lab Immunol (2004) 11(6):1158-64. doi:10.1128/CDLI.11.6.1158-1164.2004.
8. Orange JS, Belohradsky BH, Berger M, Borte M, Hagan J, Jolles S, et al. Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy. Clin Exp Immunol (2012) 169(2):172-81. doi:10.1111/j.1365-2249.2012.04594.x.
9. Orange JS, Grossman WJ, Navickis RJ, Wilkes MM. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies. Clin Immunol (2010) 137(1):21-30. doi:10.1016/j.clim.2010.06.012.
10. Lanari M, Vandini S, Capretti MG, Lazzarotto T, Faldella G. Respiratory syncytial virus infections in infants affected by primary immunodeficiency. J Immunol Res (2014) 2014:850831. doi:10.1155/2014/850831.
11. Falsey AR, Dallal G, Formica MA, Andolina GG, Hamer DH, Leka LL, et al. Long-term care facilities: a cornucopia of viral pathogens. J Am Geriatr Soc (2008) 56:1281-5. doi:10.1111/j.1532-5415.2008.01775.x.
12. Sashihara J, Burbelo P, Savoldo B, Pierson T, Cohen J. Human antibody titers to Epstein Barr Virus (EBV) gp350 correlates with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry based EBV neutralization assay. Virology (2009) 391(2):249-56.
13. Shurin PA, Rehmus JM, Johnson CE, Marchant CD, Carlin SA, Super DM, et al. Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children. J Pediatr (1993) 123:801-10. doi:10.1016/S0022-3476(05)80865-0.
14. Narwaney KJ, Glanze JM, Norris JM, Fingerlin TE, Hokanson JE, Rewers M, et al. Association of HLA class II genes with clinical hyporesponsiveness to trivalent inactivated influenza vaccine in children. Vaccine (2013) 7:1123-8. doi:10.1016/j.vaccine.2012.12.026.
15. Alper CA, Kruskall MS, Marcus-Bagley D, Craven DE, Katz AJ, Brink SJ, et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med (1989) 321:708. doi:10.1056/NEJM198909143211103.